Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
McEwen Inc
MUX
$1.29B
| $947K | ﹤0.01% |
98,767
+5,047
| +5% | +$50.4K |
|
2302
E.W. Scripps
SSP
$292M
| $945K | ﹤0.01% |
+41,347
| New | +$971K |
|
2303
STAAR Surgical
STAA
$1.15B
| $945K | ﹤0.01% |
97,835
-60,917
| -38% | -$565K |
|
2304
PDF Solutions
PDFS
$1.9B
| $944K | ﹤0.01% |
58,983
+25,125
| +74% | +$432K |
|
2305
Usana Health Sciences
USNA
$253M
| $944K | ﹤0.01% |
13,810
-54,296
| -80% | -$3.45M |
|
|
USCR
2306
DELISTED
U S Concrete, Inc.
USCR
| $939K | ﹤0.01% |
24,783
-23,661
| -49% | -$882K |
|
2307
Banco Macro
BMA
$4.99B
| $936K | ﹤0.01% |
+20,523
| New | +$1.09M |
|
|
LION
2308
DELISTED
Fidelity Southern Corporation
LION
| $936K | ﹤0.01% |
53,672
+35,749
| +199% | +$590K |
|
2309
Invesco QQQ Trust
QQQ
$486B
| $935K | ﹤0.01% |
8,735
-55,371
| -86% | -$6.02M |
|
2310
PUT
Cleveland-Cliffs
CLF
$6.58B
| $932K | ﹤0.01% |
215,300
-1,207,800
| -85% | -$6.42M |
|
|
BGFV
2311
DELISTED
Big 5 Sporting Goods
BGFV
| $931K | ﹤0.01% |
65,527
-50,461
| -44% | -$699K |
|
2312
Foster
FSTR
$395M
| $931K | ﹤0.01% |
26,900
+16,472
| +158% | +$673K |
|
|
ASCMA
2313
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
| $926K | ﹤0.01% |
21,660
-138,289
| -86% | -$5.6M |
|
|
EMBJ
2314
Embraer S.A. ADS
EMBJ
$13.4B
| $924K | ﹤0.01% |
30,500
-217,228
| -88% | -$6.7M |
|
2315
Aldeyra Therapeutics
ALDX
$94.1M
| $923K | ﹤0.01% |
+119,000
| New | +$1.03M |
|
2316
Semtech
SMTC
$13.1B
| $923K | ﹤0.01% |
+46,480
| New | +$1.08M |
|
|
WFT
2317
CALL
DELISTED
Weatherford International plc
WFT
| $920K | ﹤0.01% |
+75,000
| New | +$1.04M |
|
|
EPIQ
2318
DELISTED
EPIQ SYSTEMS INC
EPIQ
| $914K | ﹤0.01% |
54,141
+37,753
| +230% | +$653K |
|
|
ATXS
2319
DELISTED
Astria Therapeutics
ATXS
| $913K | ﹤0.01% |
+1,247
| New | +$943K |
|
2320
American States Water
AWR
$3.56B
| $911K | ﹤0.01% |
+24,377
| New | +$940K |
|
|
TRIB
2321
Trinity Biotech
TRIB
$7.8M
| $907K | ﹤0.01% |
335
-2,120
| -86% | -$5.51M |
|
|
EVOL
2322
DELISTED
Evolving Systems, Inc.
EVOL
| $907K | ﹤0.01% |
101,250
-8,750
| -8% | -$79.7K |
|
2323
Credit Acceptance
CACC
$6.16B
| $905K | ﹤0.01% |
+3,676
| New | +$814K |
|
2324
Powell Industries
POWL
$6.99B
| $904K | ﹤0.01% |
77,082
+54,318
| +239% | +$649K |
|
|
EGRX
2325
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $902K | ﹤0.01% |
11,154
-23,097
| -67% | -$1.5M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.